Michael Higgins
Stock Analyst at Ladenburg Thalmann
(n/a)
# 4,751
Out of 4,789 analysts
22
Total ratings
n/a
Success rate
-56.57%
Average return
Main Sectors:
Stocks Rated by Michael Higgins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Downgrades: Neutral | n/a | $13.48 | - | 4 | May 9, 2024 | |
| FBRX Forte Biosciences | Upgrades: Buy | $69 | $7.76 | +785.95% | 3 | Apr 8, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $7 | $0.31 | +2,144.31% | 1 | May 2, 2023 | |
| SCYX SCYNEXIS | Reiterates: Buy | $15 | $0.95 | +1,475.46% | 1 | Apr 3, 2023 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $60 | $0.88 | +6,757.14% | 2 | Apr 3, 2023 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $35 | $52.97 | -33.92% | 3 | Mar 2, 2023 | |
| PTN Palatin Technologies | Maintains: Buy | $2 → $50 | $0.58 | +8,477.80% | 1 | Sep 9, 2022 | |
| PHGE BiomX | Maintains: Buy | $130 → $80 | $0.56 | +14,296.26% | 2 | May 12, 2022 | |
| NVAX Novavax | Downgrades: Sell | $105 | $6.41 | +1,538.07% | 2 | Aug 5, 2020 | |
| VIRT Virtu Financial | Upgrades: Buy | $29 | $38.12 | -23.92% | 2 | Jan 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | n/a | $2.77 | - | 1 | Sep 27, 2017 |
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $13.48
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $7.76
Upside: +785.95%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $0.31
Upside: +2,144.31%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $0.95
Upside: +1,475.46%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $60
Current: $0.88
Upside: +6,757.14%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $52.97
Upside: -33.92%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2 → $50
Current: $0.58
Upside: +8,477.80%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $130 → $80
Current: $0.56
Upside: +14,296.26%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $6.41
Upside: +1,538.07%
Virtu Financial
Jan 4, 2019
Upgrades: Buy
Price Target: $29
Current: $38.12
Upside: -23.92%
Sep 27, 2017
Reinstates: Buy
Price Target: n/a
Current: $2.77
Upside: -